Most sellers focus all their energy on the deal – the valuation, the terms, the close date. The integration period after closing often catches them off guard. Not because it’s catastrophic, but because no one prepared them for what the first 6-12 months actually look like. Here’s an honest picture of what to expect.
The Integration Timeline Is Longer Than You Think
Even well-prepared practices typically need 6-12 months to fully adapt to their new operating environment. That timeline isn’t a sign something is wrong – it reflects the actual scope of what changes after a corporate acquisition.
During that period, the practice transitions to new accounting systems, management software, billing procedures, and operational protocols – all while maintaining the standard of patient care that justified the sale price. The buying organization is running the same process across multiple acquisitions simultaneously. Delays and course corrections are part of the process.
Close dates also shift. Due diligence requests arrive in waves. Staff communication timing gets complicated. An experienced advisor can keep the process moving and protect your interests through those changes, but sellers should plan for a longer runway than the initial LOI timeline suggests.
What Due Diligence Actually Looks Like
Corporate buyers employ professional M&A and legal teams whose job is to examine every aspect of your practice before the deal closes. That scrutiny feels invasive to most sellers who haven’t been through it before.
What they look at: financial statements, billing and collections data, patient record procedures, employment agreements, lease terms, equipment status, regulatory compliance, and operational documentation. Requests will be specific and detailed.
The framing that helps: this is standard practice, not suspicion. A buyer committing several million dollars to an acquisition is doing their job. Practices with clean records and organized documentation move through due diligence faster and with less friction.
Understanding whether a DSO is the right fit for your practice before you reach due diligence is the work that makes this stage go well.
What Changes for Your Team and Your Patients
Staff adaptation
Staff changes are one of the most common concerns selling dentists raise. Most corporate buyers are motivated to retain staff – high turnover in the months after acquisition is expensive and disruptive to patient retention, which is in the buyer’s direct financial interest.
What changes is who manages HR, how policies get communicated, and what systems staff are trained on. Your role in stabilizing the team during the transition matters more than most sellers expect. How and when you communicate the sale to staff shapes how they receive it.
Patient continuity
Patient continuity is also in the buyer’s direct financial interest. They paid for an active patient base. Everything the DSO does operationally is designed to retain that base, not disrupt it. The clinical transition from you to an ongoing employed role is something the buyer will help structure – it’s as important to them as it is to you.
Rolling Equity: What It’s Worth (and What It Isn’t)
Many DSO deals include a rolling equity component – a portion of your practice’s value that stays invested in the buying platform. If the platform grows and eventually exits to a larger buyer, that equity appreciates.
Rolling equity has produced meaningful returns for a number of PTG clients. It has also, in some cases, remained illiquid for years while the PE backer works toward an exit. The value depends on the platform’s performance, the sponsor’s fund timeline, and market conditions at the time of exit.
Evaluate it as a long-term bet, not a guaranteed return. The honest question to ask during negotiations: if this equity is worth zero at exit, does the deal still work for me financially?
How to Get Through the Integration Period Well
Set realistic expectations before close. Ask the DSO directly what the first 90 days look like. What systems change on day one? Who is your integration point of contact? What does the communication plan for staff and patients look like?
Build relationships with your new partners early. The integration team on the buyer’s side has done this before. They want the practice running well. Treating the relationship as a collaboration from day one makes the process smoother for everyone.
Maintain your clinical standards throughout. The most important thing you can do for your team and patients during the transition is continue practicing the way you always have. The business side changes. The clinical side remains yours to protect.
FAQ
How long does DSO integration typically take?
Most practices take 6-12 months to fully integrate into their new operating environment. The first 90 days involve the most significant changes – new systems, new reporting structures, new staff processes. After that, most sellers describe the rhythm as normalized. Close dates themselves often run 2-4 weeks later than originally projected due to due diligence complexity.
Will I still have clinical autonomy after selling to a DSO?
It depends on the DSO and what you negotiated. Most platforms take a hands-off approach to clinical decisions – treatment protocols, materials, and patient care remain your domain. Business decisions move to the DSO. How much clinical autonomy you retain is a real negotiating point. Get specific answers before signing, and ask to speak with prior selling doctors.
What happens to my staff after I sell to a DSO?
Most DSO buyers prioritize staff retention – turnover is expensive and disruptive to the patient care continuity they paid for. What changes is management structure: the DSO handles HR policy, benefits, and training. Most staff experience a period of adjustment in the first few months. Your leadership during that period is the most stabilizing factor available to them.
Is rolling equity worth it in a DSO deal?
Sometimes – and it depends entirely on the platform. Rolling equity is an investment in a private company, and its value depends on the buyer platform’s growth and the timing of a future exit event. When evaluating a deal with a rolling equity component, ask about the PE sponsor’s fund vintage and what prior selling doctors received in previous exits. Treat it as potential upside, not guaranteed return.
Know What to Expect Before You Close
The integration period goes better when sellers go in prepared. If you’re evaluating a DSO offer or in early discussions, our team can walk you through what the post-close experience typically looks like for practices similar to yours. Start with a baseline valuation to understand where you stand before any offer conversation begins.
